Grants and funding for social organisations

Effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe

European Union · EU

Effective and evidence-based responses to the increased availability and use of synthetic drugs and stimulants in Europe

Period: May 5, 2027 – —

Enhancing physical protection of critical infrastructures

European Union · EU

Enhancing physical protection of critical infrastructures

Period: May 5, 2027 – —

Impact of malicious use of Open-Source Intelligence on critical infrastructure business continuity

European Union · EU

Impact of malicious use of Open-Source Intelligence on critical infrastructure business continuity

Period: May 5, 2027 – —

Accelerating uptake through open proposals for advanced SME innovation

European Union · EU

Accelerating uptake through open proposals for advanced SME innovation

Period: May 5, 2027 – —

Open grounds for future pre-commercial procurement of innovative security technologies

European Union · EU

Open grounds for future pre-commercial procurement of innovative security technologies

Period: May 5, 2027 – —

Demand-led innovation in security

European Union · EU

Demand-led innovation in security

Period: May 5, 2027 – —

Key enabling technologies for fusion power plants (European Partnership on Fusion Energy)

European Union · EU

Key enabling technologies for fusion power plants (European Partnership on Fusion Energy)

Period: Apr 15, 2027 – —

HORIZON EUROPE - Civil Security for Society 2027 - 2027

European Union · EU

Who can apply Commune · Intercommunalité / Pays · Département · Région · Collectivité d’outre-mer à statut particulier · Etablissement public dont services de l'Etat · Entreprise publique locale (Sem, Spl, SemOp)

Horizon Europe - 2021-2027; Horizon Europe - Pillar 2 - Global Issues and Industrial Competitiveness - 2021-2027 ----- 129,50 millions d'euros ----- Total call budget: 129,50 millions d'euros Budget per topic: HORIZON-CL3-2027-01-FCT-01: 7,83 millions d'euros HORIZON-CL3-2027-01-FCT-02: 6 millions d'euros HORIZON-CL3-2027-01-FCT-03: 6 millions d'euros HORIZON-CL3-2027-01-FCT-04: 9 millions d'euros HORIZON-CL3-2027-01-FCT-05: 8 millions d'euros HORIZON-CL3-2027-01-BM-01: 8 millions d'euros HORIZON-CL3-2027-01-BM-02: 8 millions d'euros HORIZON-CL3-2027-01-BM-03: 14 millions d'euros HORIZON-CL3-2027-01-INFRA-01: 12 millions d'euros HORIZON-CL3-2027-01-INFRA-02: 7,67 millions d'euros HORIZON-CL3-2027-01-DRS-01: 7,67 millions d'euros HORIZON-CL3-2027-01-DRS-02: 6 millions d'euros HORIZON-CL3-2027-01-DRS-03: 9 millions d'euros HORIZON-CL3-2027-01-DRS-04: 8 millions d'euros HORIZON-CL3-2027-01-SSRI-01: 4,5 millions d'euros HORIZON-CL3-2027-01-SSRI-02: 2 millions d'euros HORIZON-CL3-2027-01-SSRI-03: 5,83 millions d'euros Grant amount: between 1 and 7,833 million...

Period: May 5, 2027 – —

Ajuntament d`Anglès (2026/8110)

LOCAL - DIPUTACIÓN PROV. DE GIRONA - DIPUTACIÓN PROVINCIAL DE GIRONA ·

Who can apply PERSONAS JURÍDICAS QUE NO DESARROLLAN ACTIVIDAD ECONÓMICA

Otras actuaciones de carácter económico

Period: Jan 1, 2026 – —

Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)

United States · US

Who can apply Others (see text field entitled "Additional Information on Eligibility" for clarification) · Special district governments · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · County governments · Private institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · For profit organizations other than small businesses · City or township governments · State governments · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Small businesses · Independent school districts

This Notice of Funding Opportunity (NOFO) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that align with the HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). These priorities were most recently described in NOT-OD-20-018 UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

United States · US

Who can apply Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · For profit organizations other than small businesses · Independent school districts · Special district governments · City or township governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal governments (Federally recognized) · Public housing authorities/Indian housing authorities · State governments · Small businesses · Native American tribal organizations (other than Federally recognized tribal governments) · Public and State controlled institutions of higher education · Private institutions of higher education · County governments · Others (see text field entitled "Additional Information on Eligibility" for clarification)

The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and behavioral symptoms. Participants in this program will receive funding for therapy development activities such as medicinal chemistry; pharmacokinetics (PK); Absorption, Distribution, Metabolism, Excretion, Toxicology (ADMET); efficacy in animal models; development of biomarkers for target engagement; formulation development; chemical synthesis under Good Manufacturing Practices (GMP); Investigational New Drug (IND) enabling studies; and initial Phase I clinical testing. Applications not responsive to this NOFO include research on basic mechanisms of disease or mechanisms of drug action; development ofrisk, diagnostic, prognostic, predictive, and preventionbiomarkers, devices, non-pharmacological interventions (e.g., exercise, diet, cognitive training), repurposed drugs and combination therapies; discovery activities such as high-throughput screening and hit optimization; and stand-alone clinical trials.

Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)

United States · US

Who can apply Independent school districts · Public housing authorities/Indian housing authorities · Others (see text field entitled "Additional Information on Eligibility" for clarification)

This limited competition Notice of Funding Opportunity (NOFO) invites renewal applications of existing NINDS-supported clinical trial cooperative agreement awards (U01) requiring additional time and resources to complete the clinical trial.

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

United States · US

Who can apply State governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Independent school districts · City or township governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Special district governments · Private institutions of higher education · For profit organizations other than small businesses · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Small businesses · County governments · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

The Theories, Models and Methods (TMM) initiative will support the development of computational tools for understanding dynamic brain circuits that are made broadly accessible to the greater research community. This program supports applications focused on tool building and dissemination in the domain of theories about neural circuit mechanisms, models of circuit structure and function, and/or computational methods of analysis spanning across scales from neurons to behavior. The development of novel theories, computational models and methods for understanding brain function will help characterize fundamental principles of brain function and organization, characterize cellular and circuit-level neural computations over time in different regions, and understand how interactions of multiple brain circuits enable flexible behaviors and contribute to brain-wide neural dynamics. These tools will be critical for developing treatments such as closed loop systems for brain disorders including Parkinsons disease and major depressive disorder.

Ajuntament de Sarrià de Ter (2026/5123)

LOCAL - DIPUTACIÓN PROV. DE GIRONA - DIPUTACIÓN PROVINCIAL DE GIRONA ·

Who can apply PERSONAS JURÍDICAS QUE NO DESARROLLAN ACTIVIDAD ECONÓMICA

Otras actuaciones de carácter económico

Period: Jan 1, 2026 – —

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)

United States · US

Who can apply Independent school districts · Private institutions of higher education · City or township governments · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · County governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public housing authorities/Indian housing authorities · Special district governments · State governments · For profit organizations other than small businesses · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses · Public and State controlled institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

The objective of the NIH Career Transition Award (K22) is to provide support to outstanding basic or clinical investigators to develop their independent research skills through a two phase program: an initial period involving an intramural appointment at the NIH and a final period of support at an extramural institution. This NINDS K22 is specifically designed to facilitate the transition of NINDS intramural neurologist- and neurosurgeon-scientists to independent, academic faculty positions that support clinician-scientists to engage in independently funded scientific research as well as clinical activities.

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)

United States · US

Who can apply County governments · State governments · Native American tribal organizations (other than Federally recognized tribal governments) · Small businesses · Native American tribal governments (Federally recognized) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Others (see text field entitled "Additional Information on Eligibility" for clarification) · For profit organizations other than small businesses · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · City or township governments · Special district governments

The objective of the NIH Career Transition Award (K22) is to provide support to outstanding basic or clinical investigators to develop their independent research skills through a two phase program: an initial period involving an intramural appointment at the NIH and a final period of support at an extramural institution. This NINDS K22 is specifically designed to facilitate the transition of NINDS intramural neurologist- and neurosurgeon-scientists to independent, academic faculty positions that support clinician-scientists to engage in independently funded scientific research as well as clinical activities.

NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)

United States · US

Who can apply Public and State controlled institutions of higher education · County governments · Native American tribal organizations (other than Federally recognized tribal governments) · Private institutions of higher education · Small businesses · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Public housing authorities/Indian housing authorities · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · For profit organizations other than small businesses · State governments · Independent school districts · Native American tribal governments (Federally recognized) · City or township governments · Special district governments

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIDA R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. This NOFO is intended to support research education activities that enhance the knowledge of substance use and substance use disorder research. The program is intended for those in clinically focused careers and/or those training for careers as clinicians/health service providers, clinical researchers, or optimally a combination of the two. This mechanism may not be used to support non-research-related clinical training.

NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)

United States · US

Who can apply Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Independent school districts · Private institutions of higher education · Small businesses · City or township governments · Special district governments · Native American tribal organizations (other than Federally recognized tribal governments) · State governments · For profit organizations other than small businesses · Native American tribal governments (Federally recognized) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Others (see text field entitled "Additional Information on Eligibility" for clarification) · County governments

The objective of the NIA Academic Leadership Career Award (K07) is to provide support for established investigators who have the expertise and leadership skills to enhance aging and/or Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD)research capacity within their academic institution. Through this award, investigators will endeavor to develop research and educational infrastructure, mentorship, and career development activities in support of new or emerging areas of aging and/or AD/ADRDresearch. These may include, but are not limited to, courses, curricula, research support, pilot funding, travel awards, visiting scholars, or networks. This Notice of Funding Opportunity (NOFO) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by another investigator.

COLLABORATION AGREEMENT BETWEEN THE DIPUTACIÓN DE SEGOVIA AND THE CÁMARA DE COMERCIO DE SEGOVIA FOR THE DEVELOPMENT OF ACTIONS WITHIN THE FRAMEWORK OF THE KNOWLEDGE TRANSFER CENTER OF THE MEAT SECTOR OF THE DIPUTACIÓN DE SEGOVIA

LOCAL - DIPUTACIÓN PROV. DE SEGOVIA - DIPUTACIÓN PROVINCIAL DE SEGOVIA ·

Who can apply PERSONAS JURÍDICAS QUE NO DESARROLLAN ACTIVIDAD ECONÓMICA

Diputación Provincial de Segovia (Segovia). Direct award call aimed at legal entities that do not carry out economic activity. Scope: agriculture, livestock, forestry and fishing, Hospitality. Grant amount of 50.000 €. Application period from 02/01/2026 to 15/11/2027.

Period: Jan 2, 2026 – —

COLLABORATION AGREEMENT BETWEEN THE DIPUTACIÓN DE SEGOVIA AND THE FEDERACIÓN EMPRESARIAL SEGOVIANA (FES) FOR THE DEVELOPMENT OF ACTIONS WITHIN THE FRAMEWORK OF THE KNOWLEDGE TRANSFER CENTER OF THE MEAT SECTOR OF SEGOVIA

LOCAL - DIPUTACIÓN PROV. DE SEGOVIA - DIPUTACIÓN PROVINCIAL DE SEGOVIA ·

Who can apply PERSONAS JURÍDICAS QUE NO DESARROLLAN ACTIVIDAD ECONÓMICA

Diputación Provincial de Segovia (Segovia). Direct award call aimed at legal entities that do not carry out economic activity. Scope: agriculture, livestock, forestry and fishing, Hospitality. Grant amount of 50.000 €. Application period from 02/01/2026 to 15/11/2027.

Period: Jan 2, 2026 – —

Ajuntament de Ribes de Freser (2026/13)

LOCAL - DIPUTACIÓN PROV. DE GIRONA - DIPUTACIÓN PROVINCIAL DE GIRONA ·

Who can apply PERSONAS JURÍDICAS QUE NO DESARROLLAN ACTIVIDAD ECONÓMICA

Otras actuaciones de carácter económico

Period: Jan 1, 2026 – —

Birth grants

LOCAL - PERDIGUERA - AYUNTAMIENTO DE PERDIGUERA ·

Who can apply PERSONAS FÍSICAS QUE NO DESARROLLAN ACTIVIDAD ECONÓMICA

Social Services and Social Promotion

CONVOCATORIA DE SUBVENCIONES EN RÉGIMEN DE EVALUACIÓN INDIVIDUALIZADA, DESTINADA A FAMILIAS PARA SUFRAGAR GASTOS EDUCATIVOS CURSO 2026-2027

LOCAL - CIZUR - AYUNTAMIENTO DE CIZUR ·

Who can apply PERSONAS FÍSICAS QUE NO DESARROLLAN ACTIVIDAD ECONÓMICA

Educación

Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)

United States · US

Who can apply City or township governments · Private institutions of higher education · Public housing authorities/Indian housing authorities · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · State governments · Native American tribal governments (Federally recognized) · Small businesses · Special district governments · Native American tribal organizations (other than Federally recognized tribal governments) · County governments · Independent school districts · Public and State controlled institutions of higher education · For profit organizations other than small businesses

The purpose of this Notice of Funding Opportunity (NOFO) is to leverage NICHD clinical research Network infrastructure relevant to infants, children, women, pregnant and lactating women, and persons with disabilities to conduct innovative, multisite, investigator-initiated clinical trials and observational studies. This NOFO will utilize a bi-phasic (UG3/UH3), milestone-driven mechanism consisting of a start-up phase (UG3) and a full enrollment and clinical trial implementation phase (UH3). Applications submitted in response to this NOFO must address specific aims and milestones for both the UG3 and UH3 phases. A UG3 project (phase I) that meets its milestones will be administratively considered by NICHD and prioritized for transition to the UH3 award (phase II). This NOFO provides an opportunity to leverage NICHD clinical research Network infrastructure as a platform for investigator-initiated innovative hypotheses by any investigator in the extramural community. Applications must be submitted as investigator-initiated, multi-Project Director/Principal Investigator (PD/PI) grant applications in conjunction with the respective NICHD-supported Network Data Coordinating Center (DCC), or equivalent as determined by the NICHD.